JARID1 Histone Demethylases: Emerging Targets in Cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Trends in Cancer

• Publication date

  2017-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.trecan.2017.08.004PMID 28958389PMCID PMC5679451
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma

  2017cited by this paper
• Is H3K4me3 instructive for transcription activation?

  2017cited by this paper
• H3K4 demethylase KDM5B regulates global dynamics of transcription elongation and alternative splicing in embryonic stem cells

  2017cited by this paper
• Regulation of oncogenic PI3-kinase signaling by JARID1B

  2017cited by this paper
• An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells.

  2016cited by this paper
• KDM5 lysine demethylases are involved in maintenance of 3′UTR length

  2016cited by this paper
• JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.

  2016influential reference
• Tumor suppressor genes that escape from X-inactivation contribute to cancer sex bias

  2016cited by this paper
• Inhibition of the histone demethylase Kdm5b promotes neurogenesis and derepresses Reln (reelin) in neural stem cells from the adult subventricular zone of mice

  2016cited by this paper
• Hypoxia-Inducible Histone Lysine Demethylases: Impact on the Aging Process and Age-Related Diseases

  2016cited by this paper
• Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition

  2016cited by this paper
• Identification of potent, selective KDM5 inhibitors.

  2016cited by this paper
• Design and evaluation of 1,7-naphthyridones as novel KDM5 inhibitors.

  2016cited by this paper
• RBP2 induces stem-like cancer cells by promoting EMT and is a prognostic marker for renal cell carcinoma

  2016cited by this paper
• Kdm5/Lid Regulates Chromosome Architecture in Meiotic Prophase I Independently of Its Histone Demethylase Activity

  2016cited by this paper
• Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131*

  2016cited by this paper
• Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma

  2016cited by this paper
• Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds.

  2016cited by this paper
• Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression

  2016cited by this paper
• Hypoxic reprograming of H3K27me3 and H3K4me3 at the INK4A locus

  2016cited by this paper
• Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex.

  2016cited by this paper
• Depletion of Histone Demethylase Jarid1A Resulting in Histone Hyperacetylation and Radiation Sensitivity Does Not Affect DNA Double-Strand Break Repair

  2016cited by this paper
• PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer.

  2016cited by this paper
• Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance

  2016cited by this paper
• Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27

  2016cited by this paper
• Discovery of KDM5A inhibitors: Homology modeling, virtual screening and structure-activity relationship analysis.

  2016cited by this paper
• JARID1D Is a Suppressor and Prognostic Marker of Prostate Cancer Invasion and Metastasis.

  2016cited by this paper
• Structural analysis of human KDM5B guides histone demethylase inhibitor development.

  2016cited by this paper
• The Histone Demethylase KDM5 Activates Gene Expression by Recognizing Chromatin Context through Its PHD Reader Motif.

  2015cited by this paper
• Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways.

  2015cited by this paper
• The histone demethylase Jarid1b is required for hematopoietic stem cell self-renewal in mice.

  2015cited by this paper
• Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases*

  2015cited by this paper
• Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer.

  2015cited by this paper
• Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP)

  2015cited by this paper
• SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage.

  2015cited by this paper
• The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential.

  2015cited by this paper
• Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC)

  2015cited by this paper
• Identification of Jumonji AT-Rich Interactive Domain 1A Inhibitors and Their Effect on Cancer Cells.

  2015cited by this paper
• Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism

  2015cited by this paper
• Epigenetic Regulation of Angiogenesis by JARID1B-Induced Repression of HOXA5

  2015cited by this paper
• Increased mitochondrial function downstream from KDM5A histone demethylase rescues differentiation in pRB-deficient cells

  2015cited by this paper
• Histone demethylase JARID1C promotes breast cancer metastasis cells via down regulating BRMS1 expression.

  2015cited by this paper
• Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell invasion through inhibition BMP7 expression

  2015cited by this paper
• Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer

  2015cited by this paper
• Immunohistochemical detection and clinicopathological significance of JARID1B/KDM5B and P16 expression in invasive ductal carcinoma of the breast.

  2015cited by this paper
• JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells

  2015influential reference
• Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia*

  2015cited by this paper
• Altered Transcriptional Control Networks with Trans-Differentiation of Isogenic Mutant-KRas NSCLC Models

  2014cited by this paper
• Coordinated Regulation of Retinoic Acid Signaling Pathway by KDM5B and Polycomb Repressive Complex 2

  2014cited by this paper
• Histone demethylase RBP2 is critical for breast cancer progression and metastasis.

  2014cited by this paper
• High temporal-resolution view of transcription and chromatin states across distinct metabolic states in budding yeast

  2014cited by this paper
• The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31

  2014cited by this paper
• Histone demethylase KDM5B is a key regulator of genome stability

  2014cited by this paper
• The PHD1 finger of KDM5B recognizes unmodified H3K4 during the demethylation of histone H3K4me2/3 by KDM5B

  2014cited by this paper
• JARID1B is a luminal lineage-driving oncogene in breast cancer.

  2014cited by this paper
• Increased progesterone receptor A expression in labouring human myometrium is associated with decreased promoter occupancy by the histone demethylase JARID1A.

  2014cited by this paper
• KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation

  2014cited by this paper
• KDM5 Interacts with Foxo to Modulate Cellular Levels of Oxidative Stress

  2014cited by this paper
• Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21.

  2014cited by this paper
• SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6/E7 promoter.

  2014cited by this paper
• Histone Demethylase Jumonji AT-rich Interactive Domain 1B (JARID1B) Controls Mammary Gland Development by Regulating Key Developmental and Lineage Specification Genes*

  2014cited by this paper
• Genomic Analysis of Head and Neck Squamous Cell Carcinoma Cell Lines and Human Tumors: A Rational Approach to Preclinical Model Selection

  2014cited by this paper
• The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers.

  2014influential reference
• Physical and Functional Interactions between the Histone H3K4 Demethylase KDM5A and the Nucleosome Remodeling and Deacetylase (NuRD) Complex*

  2014cited by this paper
• The KDM5 family of histone demethylases as targets in oncology drug discovery.

  2014influential reference
• KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomy.

  2014cited by this paper
• NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function.

  2014cited by this paper
• KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family

  2013cited by this paper
• Balancing of histone H3K4 methylation states by the Kdm5c/SMCX histone demethylase modulates promoter and enhancer function.

  2013cited by this paper
• Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis.

  2013cited by this paper
• The Histone Demethylase Jarid1b Ensures Faithful Mouse Development by Protecting Developmental Genes from Aberrant H3K4me3

  2013cited by this paper
• Targeting H3K4 trimethylation in Huntington disease

  2013cited by this paper
• Identification of Small Molecule Inhibitors of Jumonji AT-rich Interactive Domain 1B (JARID1B) Histone Demethylase by a Sensitive High Throughput Screen*

  2013cited by this paper
• RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity.

  2013cited by this paper
• Hypoxia enhances the expression of prostate-specific antigen by modifying the quantity and catalytic activity of Jumonji C domain-containing histone demethylases.

  2013cited by this paper
• Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells.

  2013cited by this paper
• Extended Self-Renewal and Accelerated Reprogramming in the Absence of Kdm5b

  2013cited by this paper
• SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase

  2013cited by this paper
• Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4‐pyridine‐dicarboxylic acid as an in vitro and in cell inhibitor

  2012cited by this paper
• Histone H3K4 demethylation is negatively regulated by histone H3 acetylation in Saccharomyces cerevisiae

  2012cited by this paper
• Cfp1 integrates both CpG content and gene activity for accurate H3K4me3 deposition in embryonic stem cells.

  2012cited by this paper
• dKDM5/LID regulates H3K4me3 dynamics at the transcription-start site (TSS) of actively transcribed developmental genes

  2012cited by this paper
• Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation

  2012cited by this paper
• Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer.

  2012cited by this paper
• Histone Demethylase KDM5B Collaborates with TFAP2C and Myc To Repress the Cell Cycle Inhibitor p21cip (CDKN1A)

  2012cited by this paper
• H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence

  2012cited by this paper
• Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis during mouse oocyte development

  2012cited by this paper
• The Histone Demethylase Jarid1b (Kdm5b) Is a Novel Component of the Rb Pathway and Associates with E2f-Target Genes in MEFs during Senescence

  2011cited by this paper
• PLU1 histone demethylase decreases the expression of KAT5 and enhances the invasive activity of the cells.

  2011cited by this paper
• KDM5B regulates embryonic stem cell self‐renewal and represses cryptic intragenic transcription

  2011cited by this paper
• Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases

  2011cited by this paper
• PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.

  2011influential reference
• Histone Lysine Demethylase JARID1a Activates CLOCK-BMAL1 and Influences the Circadian Clock

  2011cited by this paper
• Double-strand break-induced transcriptional silencing is associated with loss of tri-methylation at H3K4

  2011cited by this paper
• Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.

  2011cited by this paper
• Inaugural Article: Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1

  2011cited by this paper
• Jumonji/ARID1 B (JARID1B) Protein Promotes Breast Tumor Cell Cycle Progression through Epigenetic Repression of MicroRNA let-7e*

  2011cited by this paper
• Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex.

  2010cited by this paper
• A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

  2010influential reference
• A distinctive gene expression fingerprint in mentally retarded male patients reflects disease-causing defects in the histone demethylase KDM5C

  2010cited by this paper

• KDM5D epigenetically represses FERD3L to inhibit tumor growth in male colorectal cancer.

  2026cites this paper
• Emerging role of KDM5C in X-linked intellectual disability based on human genetic data and zebrafish models.

  2026cites this paper
• Multiple Epigenetic Mechanisms Functionally Cooperate to Silence Expression of Somatostatin Receptor Type 2 in Pancreatic Neuroendocrine Tumors

  2025cites this paper
• The mTORC2 subunit RICTOR drives breast cancer progression by promoting ganglioside biosynthesis through transcriptional and epigenetic mechanisms

  2025cites this paper
• Design of a selective peptide inhibitor targeting KDM5C demethylase activity.

  2025cites this paper
• The role of histone modifications in pulmonary hypertension: From mechanisms to therapeutic targets.

  2025cites this paper
• Prenatal arsenic exposure causes cognitive dysfunction in offspring through KDM5-regulated reprogramming of autophagy in developing brain, an effect attenuated by alpha-ketoglutarate.

  2025cites this paper
• Decoding Hepatocellular Carcinoma Metastasis: Molecular Mechanisms, Targeted Therapies, and Potential Biomarkers

  2025cites this paper
• Nuclear-localized metabolic enzymes: emerging key players in tumor epigenetic regulation

  2025cites this paper
• Lysine demethylase (KDM) inhibitors for the treatment of cancer: a patent review (2015-present)

  2025cites this paper
• Degraders in epigenetic therapy: PROTACs and beyond

  2024cites this paper
• Zinc and its binding proteins: essential roles and therapeutic potential

  2024cites this paper
• Histone demethylase enzymes KDM5A and KDM5B modulate immune response by suppressing transcription of endogenous retroviral elements

  2024cites this paper
• SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma

  2024cites this paper
• Prospects for breast cancer immunotherapy using microRNAs and transposable elements as objects

  2024cites this paper
• Identification of Proteolysis Targeting Chimeras (PROTACs) for Lysine Demethylase 5 and Their Neurite Outgrowth-Promoting Activity.

  2024cites this paper
• KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells

  2024cites this paper
• Histone demethylase JARID1C/KDM5C regulates Th17 cells by increasing IL-6 expression in diabetic plasmacytoid dendritic cells

  2024cites this paper
• Future of epigenetic immunotherapy in kidney cancer

  2024cites this paper
• Roles and Regulation of H3K4 Methylation During Mammalian Early Embryogenesis and Embryonic Stem Cell Differentiation.

  2024cites this paper
• Current State of Cold Atmospheric Plasma and Cancer‐Immunity Cycle: Therapeutic Relevance and Overcoming Clinical Limitations Using Hydrogels

  2023cites this paper
• Structural optimization of a lysine demethylase 5 inhibitor for improvement of its cellular activity.

  2023cites this paper
• PROTACs Targeting Epigenetic Proteins.

  2023cites this paper
• Prospects of epigenetic therapy of head and neck squamous cell carcinoma

  2023cites this paper
• колоректального рака

  2023cites this paper
• The Method of Viral Mimicry in Oncology and Prospects for its Improvement

  2023cites this paper
• Options for the development of colorectal cancer immunotherapy

  2023cites this paper
• PLU1 Promotes the Proliferation and Migration of Glioma Cells and Regulates Metabolism

  2023cites this paper
• Targeting epigenetic regulators to overcome drug resistance in cancers

  2023cites this paper
• Identification of Key Genes and Biological Pathways Related to Myocardial Infarction through Integrated Bioinformatics Analysis

  2023cites this paper
• Modulation of the activity of histone lysine methyltransferases and demethylases by curcumin analog in leukaemia cells

  2022cites this paper
• RICTOR Drives ZFX-mediated Ganglioside Biosynthesis to Promote Breast Cancer Progression

  2022cites this paper
• Identification of the upstream regulators of KDM5B in gastric cancer.

  2022cites this paper
• The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers

  2022cites this paper
• Histone Methylases and Demethylases Regulating Antagonistic Methyl Marks: Changes Occurring in Cancer

  2022cites this paper
• Epigenetic Mechanisms of Epidermal Differentiation

  2022cites this paper
• Joining the PARty: PARP Regulation of KDM5A during DNA Repair (and Transcription?)

  2022cites this paper
• JARID1B beim Ovarialkarzinom

  2022cites this paper
• Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator?

  2022cites this paper
• Medicinal Chemistry Research on Targeting Epigenetic Complexes

  2022cites this paper
• Functions and Interactions of Mammalian KDM5 Demethylases

  2022cites this paper
• The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy

  2022cites this paper
• KDM5A/B promotes HIV-1 latency and KDM5 inhibitors promote HIV-1 lytic reactivation

  2022cites this paper
• H3K4 di- and trimethylation modulate the stability of RNA polymerase II pausing

  2022cites this paper
• Hypo-trimethylation of Histone H3 Lysine 4 and Hyper-tri/dimethylation of Histone H3 Lysine 27 as Epigenetic Markers of Poor Prognosis in Patients with Primary Central Nervous System Lymphoma

  2021cites this paper
• KDM5B protein expressed in viable and fertile ΔARID mice exhibit no demethylase activity

  2021cites this paper
• KDM5D inhibits the transcriptional activation of FKBP4 by suppressing the expression of E2F1 in colorectal cancer in males.

  2021cites this paper
• Endogenous Retroelements and the Viral Mimicry Response in Cancer Therapy and Cellular Homeostasis.

  2021cites this paper
• Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation.

  2021cites this paper
• Spontaneous and inherited TP53 genetic alterations

  2021cites this paper
• Epigenetics in hepatocellular carcinoma.

  2021cites this paper
• KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance

  2021cites this paper
• Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple Myeloma.

  2021cites this paper
• A KDM5–Prospero transcriptional axis functions during early neurodevelopment to regulate mushroom body formation

  2021cites this paper
• JARID1-targeted histone H3 demethylase inhibitors exhibit anti-proliferative activity and overcome cisplatin resistance in canine oral melanoma cell lines.

  2021cites this paper
• Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors.

  2021cites this paper
• Design, Synthesis, and Biological Evaluation of Lysine Demethylase 5 C Degraders

  2021cites this paper
• Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions.

  2020cites this paper
• Identification of Hub Genes in Atypical Teratoid/Rhabdoid Tumor by Bioinformatics Analyses

  2020cites this paper
• Non-Coding RNAs as Mediators of Epigenetic Changes in Malignancies

  2020cites this paper
• Histone Deacetylase Inhibitors in Combinatorial Anticancer Therapy

  2020cites this paper
• JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level

  2020cites this paper
• The Drosophila histone demethylase KDM5 is required during early neurodevelopment for proper mushroom body formation and cognitive function

  2020cites this paper
• Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy

  2020cites this paper
• X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis

  2020cites this paper
• X chromosome dosage of histone demethylase KDM5C determines sex differences in adiposity.

  2020cites this paper
• KDM5C Represses FASN-Mediated Lipid Metabolism to Exert Tumor Suppressor Activity in Intrahepatic Cholangiocarcinoma

  2020cites this paper
• Identification of Hub Genes in Atypical Teratoid/Rhabdoid Tumor by Bioinformatics Analyses

  2020cites this paper
• Cancer stem cells and oral cancer: insights into molecular mechanisms and therapeutic approaches

  2020cites this paper
• IL-6 and IL-8 are involved in JMJD2A-regulated malignancy of ovarian cancer cells.

  2020cites this paper
• Epigenetic Regulator Enzymes and Their Implications in Distinct Malignancies

  2020cites this paper
• Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells.

  2019cites this paper
• Identification of ryuvidine as a KDM5A inhibitor

  2019cites this paper
• Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells

  2019cites this paper
• The Status and Impact of Clinical Tumor Genome Sequencing.

  2019cites this paper
• Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease

  2019cites this paper
• Cellular Senescence

  2019cites this paper
• Contribution of spurious transcription to intellectual disability disorders

  2019cites this paper
• Epigenomics-Guided Drug Development: Recent Advances in Solving the Cancer Treatment “jigsaw puzzle”

  2019cites this paper
• KDM5 histone-demethylases contribute to replication stress response and tolerance

  2019cites this paper
• Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes.

  2018cites this paper
• Histone demethylase JARID1B regulates proliferation and migration of pulmonary arterial smooth muscle cells in mice with chronic hypoxia-induced pulmonary hypertension via nuclear factor-kappa B (NFkB).

  2018cites this paper
• The Histone Demethylase KDM5 Is Essential for Larval Growth in Drosophila

  2018cites this paper
• An Updated Review of Oral Cancer Stem Cells and Their Stemness Regulation.

  2018cites this paper
• Epigenetic Targeting of Glioblastoma

  2018cites this paper
• Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A.

  2018cites this paper
• The Epigenetic Regulation of HCC Metastasis

  2018cites this paper
• Jumonji C Demethylases in Cellular Senescence

  2018cites this paper
• Iron Metabolism in Cancer

  2018cites this paper
• Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma

  2016cites this paper